BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• AbbVie Canada Release: More Canadians Have Access To HUMIRA (Adalimumab) For The Treatment Of Ulcerative Colitis (UC)

  August 29, 2017

   · 

  6 min read
• Business

  Bristol-Myers Squibb And Daiichi Sankyo Announce Research Collaboration To Evaluate Opdivo (Nivolumab) And DS-8201 In HER2-Expressing Breast And Bladder Cancers

  August 29, 2017

   · 

  20 min read
• Business

  MEI Pharma To Host Fiscal Year End Conference Call On September 5, 2017

  August 29, 2017

   · 

  3 min read
• Deals

  Thermo Fisher Scientific Completes Acquisition Of Patheon

  August 29, 2017

   · 

  10 min read
• Business

  Ophirex Licenses Eli Lilly-Shionogi Data For Novel Snakebite Treatment Development Program

  August 29, 2017

   · 

  4 min read
• FDA

  Boehringer Ingelheim Pharmaceuticals, Inc. Receives FDA Approval For Cyltezo (Adalimumab-Adbm), A Biosimilar To Humira, For The Treatment Of Multiple Chronic Inflammatory Diseases

  August 29, 2017

   · 

  12 min read
• Business

  AstraZeneca PLC Forges $400 Million Parkinson’s R&D Deal With Takeda

  August 29, 2017

   · 

  3 min read
• Drug Development

  Hutchison China MediTech (Chi-Med) Initiates A Phase I Clinical Trial Of Selective PI3Kd Inhibitor HMPL-689 In Lymphoma Patients In China

  August 29, 2017

   · 

  4 min read
• Business

  European Heart Rhythm Association And BIOTRONIK Mark Ten Years Of Collaboration With EHRA White Book 2017 Analysis

  August 29, 2017

   · 

  2 min read
• Drug Development

  ProQR Therapeutics Completes Dosing Of Cystic Fibrosis Patients In QR-010 Phase Ib Trial

  August 29, 2017

   · 

  5 min read